Literature DB >> 17080116

Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy.

S J Davies1.   

Abstract

Membrane function at the start of peritoneal dialysis (PD) treatment, measured as solute transport rate and ultrafiltration capacity, varies considerably between individuals. Although this can be correlated to clinical factors such as age and body habitus, this accounts for little of the variance seen. It is increasingly clear, however, that this variability in membrane function does impact on clinical outcomes. Specifically, high solute transport increases mortality risk, independent of other known factors such as age, comorbidity, and residual renal function. High solute transport causes earlier loss of the osmotic gradient when a low molecular weight osmolyte such as glucose is used. This will result in an earlier and lower peak in the ultrafiltration achieved combined with a higher fluid absorption rate once the osmotic gradient is lost. It is therefore quite plausible that the worse clinical outcomes associated with high transport reflect less good ultrafiltration, although other explanations must be considered, including higher peritoneal protein losses and a possible association with systemic inflammation. Strategies now exist to mitigate the effects of high transport on fluid removal. These include optimization of the short dwell lengths using automated PD (APD) combined with icodextrin which will result in sustained ultrafiltration and thus prevention of reabsorption in the long dwell. Survival analysis of APD patients, especially in cohorts in which icodextrin has been used, would suggest that high transport status is not a risk factor, although some of these data are only preliminary. In contrast, low ultrafiltration capacity of the membrane seems to be more important in these patients, especially if anuric. Here the best strategy would seem to be prevention as patients who develop low ultrafiltration capacity are not easily treated on PD. Avoiding excessive hypertonic glucose exposure and preserving residual renal function offers the best available approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080116     DOI: 10.1038/sj.ki.5001920

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  16 in total

1.  Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.

Authors:  Alp Akonur; Steven Guest; James A Sloand; John K Leypoldt
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  Peritoneal Equilibration Test and Patient Outcomes.

Authors:  Rajnish Mehrotra; Vanessa Ravel; Elani Streja; Sooraj Kuttykrishnan; Scott V Adams; Ronit Katz; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-13       Impact factor: 8.237

3.  Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study.

Authors:  Alp Akonur; James Sloand; Ira Davis; John Leypoldt
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

4.  Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Elaine M Pascoe; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

5.  High peritoneal transport status is not an independent risk factor for high mortality in patients treated with automated peritoneal dialysis.

Authors:  Tae Ik Chang; Jung Tak Park; Dong Hyung Lee; Ju Hyun Lee; Tae Hyun Yoo; Beom Seok Kim; Shin-Wook Kang; Ho Yung Lee; Kyu Hun Choi
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

6.  Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Justin A Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

Review 7.  Peritoneal dialysis--current status and future challenges.

Authors:  Simon J Davies
Journal:  Nat Rev Nephrol       Date:  2013-05-21       Impact factor: 28.314

8.  Measuring peritoneal absorption with the prolonged peritoneal equilibration test from 4 to 8 hours using various glucose concentrations.

Authors:  Josep Teixidó-Planas; Maria Isabel Troya-Saborido; Guillermo Pedreira-Robles; Milagros Del-Rio-Lafuente; Ramon Romero-Gonzalez; Josep Bonet-Sol
Journal:  Perit Dial Int       Date:  2014 Sep-Oct       Impact factor: 1.756

9.  Hydration status does not influence peritoneal equilibration test ultrafiltration volumes.

Authors:  Andrew Davenport; Michelle Kay Willicombe
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-25       Impact factor: 8.237

10.  Peritoneal transport: getting more complicated.

Authors:  James G Heaf
Journal:  Nephrol Dial Transplant       Date:  2012-10-04       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.